REQUEST A DEMO
Total
USD $0.00
Search more companies

Genlab S.A.S. (Colombia)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Genlab S.A.S. Profile Updated: May 17, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Genlab S.A.S. is a company based in Colombia, with its head office in Bogota D.C.. The company operates in the Pharmaceutical Preparation Manufacturing sector. It was first established on March 19, 2020. Genlab S.A.S. currently employs 7 (2024) people. In its most recent financial highlights, the company reported a net sales revenue increase of 44.44% in 2023. Its total assets grew by 99.53% over the same period. The net profit margin of Genlab S.A.S. increased by 4.27% in 2023.

Headquarters
Calle 74 10 47 Ofc 307
Bogota D.C.; Bogota D.C; Postal Code: 0803

Contact Details: Purchase the Genlab S.A.S. report to view the information.

Basic Information
Total Employees:
Purchase the Genlab S.A.S. report to view the information.
Outstanding Shares:
Purchase the Genlab S.A.S. report to view the information.
Incorporation Date:
March 19, 2020
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Alternate Legal Representative
Purchase this report to view the information.
Fiscal Inspector
Company Performance
Financial values in the chart are available after Genlab S.A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
44.44%
Total operating revenue
44.44%
Operating profit (EBIT)
480.2%
Net Profit (Loss) for the Period
245.49%
Total assets
99.53%
Total equity
237.48%
Operating Profit Margin (ROS)
9.26%
Net Profit Margin
4.27%
Return on Equity (ROE)
0.99%
Quick Ratio
0.17%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?